In February, the Central Drugs Standard Control Organization had authorized the use of Corbevax for adolescents ages 12 to 18. But within weeks, it was revealed that the National Technical Advisory Group on Immunisation had questioned whether Biological E had shown the vaccine is effective.
[Science Insider]
